- Home
- VABK vs SLS Comparison
VABK vs SLS Comparison
Compare VABK & SLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VABK
- SLS
- Stock Information
- Founded
- VABK 1998
- SLS 2012
- Country
- VABK United States
- SLS United States
- Employees
- VABK N/A
- SLS N/A
- Industry
- VABK Major Banks
- SLS Biotechnology: Pharmaceutical Preparations
- Sector
- VABK Finance
- SLS Health Care
- Exchange
- VABK Nasdaq
- SLS Nasdaq
- Market Cap
- VABK 201.8M
- SLS 165.6M
- IPO Year
- VABK N/A
- SLS N/A
- Fundamental
- Price
- VABK $36.88
- SLS $1.58
- Analyst Decision
- VABK
- SLS Strong Buy
- Analyst Count
- VABK 0
- SLS 1
- Target Price
- VABK N/A
- SLS $7.00
- AVG Volume (30 Days)
- VABK 5.5K
- SLS 2.3M
- Earning Date
- VABK 07-24-2025
- SLS 08-19-2025
- Dividend Yield
- VABK 3.93%
- SLS N/A
- EPS Growth
- VABK 14.13
- SLS N/A
- EPS
- VABK 3.31
- SLS N/A
- Revenue
- VABK $56,012,000.00
- SLS N/A
- Revenue This Year
- VABK N/A
- SLS N/A
- Revenue Next Year
- VABK N/A
- SLS N/A
- P/E Ratio
- VABK $11.07
- SLS N/A
- Revenue Growth
- VABK 8.12
- SLS N/A
- 52 Week Low
- VABK $33.53
- SLS $0.77
- 52 Week High
- VABK $44.00
- SLS $2.27
- Technical
- Relative Strength Index (RSI)
- VABK 46.32
- SLS 38.26
- Support Level
- VABK $36.60
- SLS $1.56
- Resistance Level
- VABK $37.29
- SLS $1.71
- Average True Range (ATR)
- VABK 0.54
- SLS 0.10
- MACD
- VABK -0.10
- SLS -0.02
- Stochastic Oscillator
- VABK 15.14
- SLS 5.00
About VABK Virginia National Bankshares Corporation
Virginia National Bankshares Corp is a bank holding company which is engaged in the commercial and retail banking business. The bank offers a range of banking and related financial services, including checking accounts, negotiable order of withdrawal accounts, money market deposit accounts, certificates of deposit, individual retirement accounts and other depository services. Its segments include the Bank, VNB Trust and Estate Services, Sturman Wealth Advisors, and Masonry Capital. The Bank's commercial banking activities involve making loans, taking deposits and offering related services to individuals, businesses, and charitable organizations.
About SLS SELLAS Life Sciences Group Inc.
SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.